Formulation Perspectives in Topical Antifungal Drug Therapy: A Review
FORMULATION PERSPECTIVES IN TOPICAL DRUG DELIVERY
Abstract
Topical medication delivery is the process of directly treating a cutaneous ailment or the cutaneous manifestation of a general disease by applying a pharmaceutical dosage form to the skin with the goal of reducing the drug's pharmacological or other effects to the surface of skin. A wide range of pharmacological dosage forms, such as semisolids, liquid preparations, sprays, solid powders, gels, creams, and ointments, are used in topical drug delivery systems. A gel is a cross-linked polymer network swollen in a liquid medium. Its properties depend strongly on the interaction between solid state polymer and the liquid component. Gels don't have a flow that is steady. An interlacing three-dimensional network of dispersed phase particles is created by the interaction of the polymer and the liquid dispersion medium. Because topical gel formulations are less oily and readily removed from the skin, they provide an effective medication delivery mechanism. Compared to cream and ointments, gel composition offers greater application properties and stability. One of the most frequent issues with dermatological problems is fungal infection of the skin. The most effective option for treating cutaneous infections is topical treatment. The most popular antifungals in the treatment of both local and systemic fungal infections are azoles. The benefits of topical treatment for fungal infections include less risk of systemic adverse effects and medications that are targeted to the infection site. Important actions for boosting treatment effectiveness include formulation design and optimization. The most helpful aspects of a topical medication delivery system are the medication's physiochemical characteristics and formulation type. As a result, some recent developments in formulation have been researched for the delivery of antifungal medications via the target region of the skin. This review focuses on the research that has been done so far on antifungal gel and a thorough analysis of it.
Keywords: Topical gel, Antifungal, Drug delivery, dispersion medium, fungal infection, adverse effects
Keywords:
Topical gel, Antifungal, Drug delivery, dispersion medium, fungal infection, adverse effectsDOI
https://doi.org/10.22270/jddt.v13i5.6079References
Swarupanjali PA, Gauniya PS, Das PS and Rohit B, Evolutionary Aspect of Antifungal Topical Gel-A Review, 2018; 8(1):015-030.
Paye M, Barel AO And Maibach HI, Handbook of Cosmetic Science and Technology, 2005 (2nd Edition). https://doi.org/10.1201/b14400
Bareggi SR, Pirola R, and De Benedittis G, Skin and Plasma Levels of Acetylsalicylic Acid: A Comparison between Topical Aspirin/Diethyl Ether Mixture and Oral Aspirin in Acute Herpes Zoster and Postherpetic Neuralgia, European Journal of Clinical Pharmacology, 1998; 54(3):231–235. https://doi.org/10.1007/s002280050451.
Gisby J and Bryant J, Efficacy of A New Cream Formulation of Mupirocin: Comparison with Oral and Topical Agents In Experimental Skin Infections. Antimicrobial Agents and Chemotherapy, 2000; 44(2):255–260. https://doi.org/10.1128/aac.44.2.255-260.2000.
Salunkhe KN, Review On: Anti-Inflammatory Herbal Gel of Boswellia Serrata & Vitex Negundo, In International Journal of Pharmacy and Biological Sciences, 2013; 23(2):374-382.
Verma A, Singh S, Kaur R, Upendra KJ, Topical Gels as Drug Delivery Systems: A Review, International Journal of Pharmaceutical Sciences Review and Research, 2013; 23(2):374-382.
Ansel HC, Popovich NG, Loyd VA, Pharmaceutical Dosage Forms and Drug Delivery Systems, 9, B. I. Publications, New Delhi, 2005, 407-408.
Carter SJ, Disperse System In: Cooper and Gunn’s Tutorial Pharmacy, 6, CBS Publishers And Distributors, New Delhi, 2000, 68-72.
Lieberman HA, Rieger MM, Banker GS, Pharmaceutical Dosage Form: Disperse System, 2, Marcel Dekker, 2005, 399-421.
Saeeda W,Singh S, Sharique A, Fungal Diseases of Gynecological Aspect: A Review, Scholars International Journal of Obstetrics And Gynecology,2021; 4(9):360- 368. https://doi.org/10.36348/sijog.2021.v04i09.005.
Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, Marks R, Naldi L, Weinstock MA, Wulf SK, Michaud CJ, Murray CV and Naghavi M. The Global Burden of Skin Disease In 2010: An Analysis of The Prevalence and Impact of Skin Conditions. Journal of Investigative Dermatology, 2014; 134(6):1527–1534.https://doi.org/10.1038/jid.2013.446.
Article R, Glujoy M, Salerno C, Bregni C, Carlucci AM, Percutaneous Drug Delivery Systems for Improving Antifungal Therapy Effectiveness: A Review, International Journal of Pharmacy and Pharmaceutical Sciences, 2014; 6(6): 8-16.
Neubert AS, Reinhard HH, Potentials of New Nanocarriers for Dermal and Transdermal Drug Delivery, European Journal of Pharmaceutics and Biopharmaceutics, 2011; 77(1):1–2.https://doi.org/10.1016/j.ejpb.2010.11.003.
Benson H, Elastic Liposomes for Topical and Transdermal Drug Delivery, Current Drug Delivery, 2012; 6(3):217–226. https://doi.org/10.2174/156720109788680813.
Millikan LE, Current Concepts in Systemic and Topical Therapy for Superficial Mycoses. Clinics In Dermatology, 2010; 28(2):212–216. https://doi.org/10.1016/j.clindermatol.2009.12.016.
King CT, Rogers P, David C, John D. And Chapman SW, Antifungal Therapy During Pregnancy Clinical Infectious Diseases , An Official Publication of The Infectious Diseases Society of America, 1998; 27(5):1151–1160. https://doi.org/10.1086/514977.
Patel DD, Sandipan DS, Roja RY, Ray S and Mazumder B, Nanostructured Lipid Carriers (NLC)-Based Gel for The Topical Delivery of Aceclofenac: Preparation, Characterization, And In-vivo Evaluation, Scientia Pharmaceutica, 2012; 80(3):749.https://doi.org/10.3797/scipharm.1202-12.
Bhowmik HG, Venkatesh D, Nagasamy K, Anuttam K, Kammari HH, Nanosponges: A Review, International Journal of Applied Pharmaceutics, 2018; 10(4):1–5. https://doi.org/10.22159/ijap.2018v10i4.25026.
Hiremath SN, Godge GR, Sonawale BG, Shirsath RA, Pharmaceutical Advances In Cyclodextrin Inclusion Complexes For Improved Bioavailability Of Poorly-Soluble Drugs, International Journal of Pharmaceutical Sciences and Nanotechnology, 2015; 8(3):2894-2905. https://doi.org/10.37285/ijpsn.2015.8.3.2
Glotzer SC, Solomon MJ, Anisotropy of Building Blocks and Their Assembly Into Complex Structures, Nature Materials, 2007; 6(8):557–562. https://doi.org/10.1038/nmat1949.
Sriaandhal SL, Malitha AS, A Review on Emerging Applications of Emulgel As Topical Drug Delivery System, World Journal of Advanced Research and Reviews, 2022; 13(01):452–463. https://doi.org/10.30574/wjarr.2022.13.1.0048.
Kovarik JM., Mueller EA, Van B, Johannes B, Tetzloff W,and Kutz K, Reduced Inter- and Intraindividual Variability in Cyclosporine Pharmacokinetics from A Microemulsion Formulation, Journal Of Pharmaceutical Sciences, 1994; 83(3):444–446. https://doi.org/10.1002/jps.2600830336.
Noble S, Markham A, Cyclosporin. A Review of The Pharmacokinetic Properties, Clinical Efficacy and Tolerability of a Microemulsion-Based Formulation (Neoral), Drugs, 1995; 50(5):924–941. https://doi.org/10.2165/00003495-199550050-00009.
Sahu Gk, Sharma H, Gupta A and Kaur CD, Advancements In Microemulsion Based Drug Delivery Systems for Better Therapeutic Effects, International Journal of Pharmaceutical Sciences and Developmental Research, 2015;1(1):008–015. https://www.academia.edu/16902327/advancements_in_microemulsion_based_drug_delivery_systems_for_better_therapeutic_effects https://doi.org/10.17352/ijpsdr.000003
Gurpreet K And Singh SK, Review Of Nanoemulsion Formulation and Characterization Techniques, Indian Journal of Pharmaceutical Sciences, 2018;80(5):781–789. https://doi.org/10.4172/pharmaceutical-sciences.1000422.
Yadav SK, Mishra MK, Tiwari A, and Shukla A, Emulgel: A New Approach for Enhanced Topical Drug Delivery, International Journal of Current Pharmaceutical Research, 2016; 9(1):15. https://doi.org/10.22159/ijcpr.2017v9i1.16628.
Hemendrasinh JR,Dhruti PM, A Review on Pharmaceutical Gel, International Journal of Pharmaceutical Sciences, 2015; 1(1):33-47.
Kaur L, Preet, Garg R, Gupta GD, Topical Gels: A Review, Research Journal of Pharmacy and Technology, 2010; 3(1):17-24.
Sanap D, Garje M, Godge G, Probiotics, their Health Benefits and Applications for development of Human Health: A Review, Journal of Drug Delivery and Therapeutics. 2019; 9(4-s):631-640.
Hiremath S, Godge G, Sonawale B and Shirsath R, Pharmaceutical Advances In Cyclodextrin Inclusion Complexes For Improved Bioavailability Of Poorly-Soluble Drugs, International Journal of Pharmaceutical Sciences and Nanotechnology, 2015; 8(3):2894-2905. https://doi.org/10.37285/ijpsn.2015.8.3.2
Godge GR, Garje MA, Dode AB, Tarkase KN. Nanosuspension Technology for Delivery of Poorly Soluble Drugs and Its Applications: A Review, Int. J. Pharm. Sci. Nanotech, 2020; 13(4):4965-4978. https://doi.org/10.37285/ijpsn.2020.13.4.1
Godge GR, and Hiremath SN, An Investigation into the Characteristics of Natural Polysaccharide: Polymer Metoprolol Succinate Tablets for Colonic Drug Delivery, Mahidol University Journal of Pharmaceutical Sciences, 2014; 41(2):7-21.
Published
Abstract Display: 823 
PDF Downloads: 663 PDF Downloads: 48 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.